Search Orphan Drug Designations and Approvals
-
Generic Name: | vebreltinib |
---|---|
Date Designated: | 08/16/2022 |
Orphan Designation: | Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Apollomics, Inc. 989 E. Hillsdale Blvd, Suite 220 Foster City, California 94404 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-